Source recordFED

Somru BioScience Inc.

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2020· $418,486· BN 806733887· PE

Description

Somru BioScience Inc. intends to develop fully integrated therapeutic antibody discovery platform that allows us to unlock complex targets and enable discovery of novel and rare antibodies with therapeutic potential.

Amendment chain · 4 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $404,263 at start, $418,486 after amendment #3 (+$14,223).

$418,486$0Original · 2020-01-22 (start date) · total $404,263Amendment 1 · 2021-01-29 · total $383,486Amendment 2 · 2021-11-22 · total $418,486Amendment 3 · 2022-01-28 · total $418,486
  • #02020-01-22$404,263
  • #12021-01-29$383,486-$20,777
  • #22021-11-22$418,486+$35,000
  • #32022-01-28$418,486
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2020-01-22(start date)$404,263—Somru BioScience Inc. intends to develop fully integrated therapeutic antibody discovery platform that allows…
#1 amendment2021-01-29$383,486−$20,777Somru BioScience Inc. intends to develop fully integrated therapeutic antibody discovery platform that allows…
#2 amendment2021-11-22$418,486+$35,000Somru BioScience Inc. intends to develop fully integrated therapeutic antibody discovery platform that allows…
#3 amendment2022-01-28$418,486+$0Somru BioScience Inc. intends to develop fully integrated therapeutic antibody discovery platform that allows…

Related records · 11

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 806733887)

RefDepartment · programCurrent valueFY
276-2025-2026-Q4-00103Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI-BSP-Regional Tariff Response Initiative (RTRI)$747,500FY2026
276-2025-2026-Q4-00084Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI - Strategic Growth Initiative (SGI)$50,000FY2026
064-2025-2026-Q2-00089Global Affairs Canada | Affaires mondiales Canada · Grant Canadian Inter. Innovation Prog$2,927FY2026
172-2025-2026-Q2-1031776National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$1,000,000FY2026
276-2022-2023-Q3-00103Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI - Business Scale-up and Productivity$700,000FY2023
276-2022-2023-Q2-00417Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI - Business Scale-up and Productivity$1,250,000FY2023

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2019-2020-Q4-942027 · retrieved 2026-11-16.